Thyroid cancer: open trials in China

• NCT06359847

  Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

  Trial Treatment · Phase 2 · Beijing Scitech-Mq Pharmaceuticals Limited

  Peking Union Medical College Hospital, Beijing

  Registry updated 2026-11-05

• NCT07914764

  68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis

  Research · Nanjing First Hospital, Nanjing Medical University

  Nanjing First Hospital, Nanjing

  Registry updated 2026-11-04

• NCT07874321

  MRG003 Added to Ongoing Treatment After Progression in EGFR-Positive Advanced Thyroid Cancer

  Trial Treatment · Phase 2 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  Sun Yat Sen Memorial Hospital of Sun Yat sen University, Guangzhou

  Registry updated 2026-10-14

• NCT05786924

  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Trial Treatment · Phase 1/2 · Institut de Recherches Internationales Servier

  Beijing Cancer Hospital, Beijing · Shandong Cancer Hospital (Cancer Hospital of Shandong First Medical University), Jinan · Fudan University Zhongshan Hospital, Shanghai · The Second Affiliated Hospital of Soochow University, Suzhou

  Registry updated 2026-10-13

• NCT06738888

  Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy

  Research · Shanghai 6th People's Hospital

  Shanghai Sixth People's Hospital, Shanghai

  Registry updated 2026-10-08

• NCT07707401

  Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy

  Trial Treatment · Shanghai 6th People's Hospital

  Shanghai Sixth People's Hospital, Shanghai

  Registry updated 2026-09-10

• NCT03177902

  Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer

  Research · The First Affiliated Hospital of Bengbu Medical University

  Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu

  Registry updated 2026-09-04

• NCT07459283

  The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

  Trial Treatment · Early phase 1 · FindCure Biosciences (ZhongShan) Co., Ltd.

  Affiliated Hospital of Jiangnan University, Wuxi

  Registry updated 2026-09-04

• NCT07776262

  Safety and Efficacy of Cryoablation for Thyroid Tumors

  Trial Treatment · Yukun Luo

  Chinese People's Liberation Army General Hospital, Beijing

  Registry updated 2026-08-20

• NCT07777536

  Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer

  Trial Treatment · Phase 2 · Fudan University

  Fudan Universtiy Shanghai Cancer Center, Shanghai

  Registry updated 2026-08-20

• NCT06931743

  The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery

  Trial Treatment · Xiaonan Huang

  the Specialised Medical Centre of the Chinese People's Liberation Army Navy, Shanghai · Changzheng Hospital Affiliated to the Naval Medical University, Shanghai · Changhai Hospital Affiliated to the Naval Medical University, Shanghai

  Registry updated 2026-08-19

• NCT07755423

  Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study

  Research · Fudan University

  Fudan University Shanghai Cancer Center, Shanghai

  Registry updated 2026-08-10

• NCT07753499

  Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer

  Trial Treatment · The First Affiliated Hospital of Xiamen University

  The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, Xiamen

  Registry updated 2026-08-07

• NCT07328243

  Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

  Trial Treatment · Tian'an Jiang

  The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

  Registry updated 2026-07-23

• NCT07302672

  Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

  Trial Treatment · Ming-an Yu

  China-Japan Friendship Hospital, Beijing

  Registry updated 2026-07-14

• NCT07244835

  A Study of DEG6498 in Participants With Solid Tumors

  Trial Treatment · Phase 1 · Degron Therapeutics Co.

  Beijing Cancer Hospital, Beijing · Beijing GoBroad Hospital, Beijing · Sun Yat-sen University Cancer Center, Guangzhou

  Registry updated 2026-06-30

• NCT07649200

  Study of SNH-118110 in Advanced Solid Tumors

  Trial Treatment · Phase 1 · ScinnoHub Pharmaceutical Co., Ltd.

  The East Hospital Affiliated to Tongji University, Shanghai, Shanghai

  Registry updated 2026-06-16

• NCT07634978

  Development and Application of an AI Chatbot for Perioperative Health Education in Thyroid Cancer Patients

  Trial Treatment · Tianjin Medical University Cancer Institute and Hospital

  Tianjin Medical University Cancer Institute and Hospital, Tianjin

  Registry updated 2026-06-09

• NCT07628543

  Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery

  Research · Fujian Medical University

  Fujian Medical University Union Hospital, Fuzhou

  Registry updated 2026-06-05

• NCT07068542

  Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

  Trial Treatment · Zhejiang Provincial People's Hospital

  Zhejiang Provincial People's Hospital, Hangzhou

  Registry updated 2026-06-01

• NCT06851663

  Trop2-targeted immunoPET Imaging of Solid Tumors

  Trial Treatment · Phase 2/3 · RenJi Hospital

  Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

  Registry updated 2026-05-29

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Beijing · Beijing Cancer Hospital, Beijing · Jilin Cancer Hospital/Medical Oncology Department, Changchun · The first hospital of Jilin university-Oncology Department, Changchun · Changsha · Hunan Cancer Hospital-thoracic oncology II, Changsha · The Third Xiangya Hospital of Central South University/Department of Respiratory and Critical Care Medicine, Changsha · Sichuan Cancer Hospital/Medical Oncology Department, Chengdu · West China Hospital Sichuan University/Lung cancer center, Chengdu · The First Hospital Affiliated To AMU - Southwest Hospital, Chongqing · Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /Cancer Center, Daping · Fuzhou · Guangdong Provincial People's Hospital, Guangzhou · Guangzhou · Hangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Zhejiang Cancer Hospital-Oncology, Hangzhou · The Affiliated Tumor Hospital of Harbin Medical University, Harbin · Anhui Provincial Hospital, Hefei · Nanjing · Shanghai Chest Hospital, Shanghai · Shatin · Liaoning Cancer Hospital, Shenyang · Shenzhen · Shanxi Bethune Hospital, Taiyuan · Weifang People's Hospital/Medical Oncology Department, Weifang · Wuhan · The First Affiliated hospital of Xiamen University-oncology, Xiamen · Tangdu Hospital, Xi'an · XuZhou Central Hospital/Oncology Department, Xuzhou · Henan Cancer Hospital/The 1st pneumology department, Zhengzhou

  Registry updated 2026-05-27

• NCT06671184

  Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy

  Research · Shanghai 6th People's Hospital

  Shanghai Sixth People's Hospital, Shanghai

  Registry updated 2026-05-07

• NCT06730321

  Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

  Research · Shanghai 6th People's Hospital

  Shanghai Sixth People's Hospital, Shanghai

  Registry updated 2026-05-07

• NCT06141369

  Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

  Trial Treatment · Shanghai Jiao Tong University School of Medicine

  Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

  Registry updated 2026-04-09

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error